Pacific Biomarkers, Inc. is a premier biomarker laboratory services provider in the Drug Development Industry supporting preclinical and Phase I-IV studies. Since 1989, PBI has partnered with the Pharmaceutical, Biotech and Diagnostic Manufacturing Industries to provide biomarker laboratory services. Due to these partnerships and our dedicated clinical chemists we have optimized study outcomes, decreased sponsors’ timelines for FDA approval, and provided competitive product differentiation.
Specialties
Cardiovascular Risk, Metabolic Diseases, Musculoskeletal, Inflammation, Nutritional Health, Immunogenicity Testing, Novel Biomarker Assay Development, Cell Based Assays, Multiplexing, Technology Transfer
